Tanaka, Makoto
Kawakami, Aki
Sakagami, Kayoko
Terai, Tomoko
Fernandez, Jovelle
Keefer, Laurie
Ito, Hiroaki
Funding for this research was provided by:
Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering
Takeda Pharmaceutical Company
Article History
Received: 13 November 2023
Accepted: 15 March 2024
First Online: 31 May 2024
Declarations
:
: The survey was carried out with the approval of the ethics committees of the university and hospital where recruitment was conducted (approval no. M2019-052, 2019-5), and all patients gave informed consent to participate in the study.
: Not applicable.
: M.T., A.K., K.S., and H.I. have no conflict of interests. T.T. is and J.F. was an employee of Takeda. J.F. owns restricted stocks in Takeda and GlaxoSmithKline, and is a major shareholder of Immunorock. Co., Ltd. L.K. is a consultant to Reckitt Health, Takeda, AbbVie, Eli Lilly, and Pfizer. L.K. is also a co-founder and equity owner of Trellus Health.